Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 75.00 | |
25 mg | In stock | $ 128.00 | |
50 mg | In stock | $ 192.00 | |
100 mg | In stock | $ 287.00 | |
200 mg | In stock | $ 431.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 83.00 |
Description | ABT-080 (VML 530), a leukotriene synthesis inhibitor, is used potentially for treatment of asthma. |
In vitro | ABT-080 Inhibits calcium ionophore (A-23187)-stimulated LTB4 formation in human neutrophils with IC50 of 20nM. ABT-080 inhibits LTB4 production with an IC50 of 13000nM in a calcium ionophore-stimulated human whole blood assay. |
Synonyms | VML530, VML-530, VML 530, ABT080 |
Molecular Weight | 590.64 |
Formula | C37H31N2NaO4 |
CAS No. | 189498-57-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (84.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT-080 189498-57-5 GPCR/G Protein Leukotriene Receptor VML530 ABT 080 VML-530 VML 530 ABT080 inhibitor inhibit